NexGel Inc (NXGL)
NXGL trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$4.05
+6.30% on the day
Market cap
$2.0M
Nano cap
Revenue · 2025
$11.4M
+31.5% on 2024
Net income · 2025
-$3.0M
-26.3% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | NXGL on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001468929 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $11.4M |
| Net income | -$3.0M |
| Operating income | -$3.4M |
| Net margin | -26.3% |
| Operating margin | -29.3% |
| Revenue growth | +31.5% |
| Cash | Not in SEC XBRL data |
| Total assets | $10.5M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.2× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-1 | 2026-08-20 |
| Latest annual report | 10-K/A | 2026-04-30 |
| Latest quarterly / interim | 10-Q | 2026-08-17 |
| Latest current report | 8-K | 2026-10-07 |
| Latest proxy | DEF 14A | 2026-08-24 |
Source: SEC EDGAR submissions feed, 327 recent filings. All filings on EDGAR.
Other listings for this company
| Ticker | Name | Price |
|---|---|---|
| NXGLW | NexGel Inc Warrant | $0.0090 |
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| XAIR | Beyond Air Inc. | $2.19 | -5.20% | $2.1M |
| VJET | Flyte Aviation Inc. | $1.06 | +6.00% | $2.2M |
| IVF | INVO Fertility Inc. | $0.6399 | -11.86% | $2.9M |
| ADGM | Adagio Medical Holdings Inc | $0.1253 | -5.08% | $3.4M |
| BJDX | Bluejay Diagnostics Inc. | $0.8323 | +5.06% | $3.7M |
| ICCM | IceCure Medical Ltd. | $1.10 | +1.85% | $3.8M |
| GCTK | GlucoTrack Inc. | $1.11 | -4.31% | $942K |
| VVOS | Vivos Therapeutics Inc. | $0.1416 | -1.80% | $4.8M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier